Pioneering Wearable Pain Relief Technology
Our mission is to help people with chronic pain live their best lives. We are committed to empowering people to reclaim their lives from chronic pain and believe that technology can play a central role. We combine advanced neurostimulation with innovative design to bring high technology, high quality pain relief solutions to people suffering from chronic pain.
Quell® wearable pain relief technology was created by the scientists and biomedical engineers at NeuroMetrix, Inc. (Nasdaq: NURO). The company was started in 1996 by Dr. Shai N. Gozani, while conducting scientific research at the Massachusetts Institute of Technology. The scientists and engineers at NeuroMetrix have spent over 20 years developing breakthrough neurodiagnostic and wearable pain relief products. The company has been granted over 70 patents and published numerous scientific papers and abstracts.
- Our Team
SHAI N. GOZANI, M.D., PH.D.PRESIDENT AND CHIEF EXECUTIVE OFFICER
Dr. Gozani founded NeuroMetrix, Inc. in 1996 as a spin-off from the Massachusetts Institute of Technology. He currently serves as Chairman of the Board of Directors and as President and Chief Executive Officer. Dr. Gozani has led the Company from a venture capital backed start-up, through an initial public offering on Nasdaq, through development of a successful diagnostics business, and presently into the wearable technology sector. Over 4 million patients have benefited from the Company’s technology over the past 20 years.
Dr. Gozani is an expert in non-invasive neurostimulation. He received his M.D. degree from Harvard Medical School and the Harvard-MIT Division of Health Science and Technology. Dr. Gozani earned his Ph.D. in Neurobiology, M.S. in Electrical Engineering & Computer Science and B.A. in Computer Science from the University of California at Berkeley. Following his studies, Dr. Gozani conducted post-doctoral research at Harvard Medical School and MIT. He holds 36 U.S. patents and has authored over 30 articles in scientific and clinical peer-reviewed journals.
THOMAS T. HIGGINSCHIEF FINANCIAL OFFICER
Mr. Higgins contributes a broad set of financial management and operations skills from his CFO experience with publicly traded companies in multiple industries such as life sciences, specialty chemicals and financial services. These companies included Caliper Life Sciences, V.I. Technologies and Cabot Corporation. He has extensive international experience with a particular emphasis on Japan, Southeast Asia and the Middle East.
Mr. Higgins started his career with PricewaterhouseCoopers and holds a B.B.A. with honors from Boston University.
XUAN KONG, PH.D.CHIEF DATA SCIENTIST
Xuan Kong joined the company in 1999. In his current role, he leads the company’s data scienceinitiative by leveraging the data assets collected from Company’s products to deliver personalized and clinically optimized pain relief and health experience for customers. In addition, he provides leadership and technology contributions for the Company’s basic research and product development functions. Xuan also manages the Company’s intellectual property portfolio and external research collaborations. He has published numerous papers in leading signal processing, biomedical engineering, and clinical neurophysiology journals. Xuan has been awarded more than twenty U.S. and foreign patents.
Prior to joining the company, Xuan was a tenured associate professor in the Department of Electrical Engineering at Northern Illinois University. As a principal investigator, he successfully led many federally and industrially funded projects in signal processing research and bio-electric signal analysis applications.
Xuan received his Ph.D. from The Johns Hopkins University and MBA from Boston University. He is certified as professional risk manager by PRMIA. He is a senior member of IEEE and a member of Eta Kappa Nu and Beta Gamma Sigma.